An oral plant exosome hydrogel for targeted regulation of the intestine and its preparation method and application
By using porous starch and sodium alginate in plant exosomes to form a composite gel, combining small peptide D3 and mixed phospholipids, the problems of plant exosomes in storage and application are solved, and stability and targeting are achieved. Improve to ensure effective regulation of intestinal health in the intestine.
Patent Information
- Application Number
- CN202211626953.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-12-16
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2042-12-16
AI Technical Summary
In storage and application, existing plant exosomes have problems such as low concentration, easy structure destruction, low targeting efficiency and uncontrollable release, which are difficult to effectively regulate intestinal health.
Porous starch and sodium alginate are used to form a composite gel, embedded in plant exosomes, combined with small peptide D3 and mixed phospholipids, and through multi-stage embedding process and pH adjustment, a stable oral plant exosome hydrogel is formed to ensure that Slowly release exosomes in gastric acid and intestinal environments.
It improves the stability and targeting of plant exosomes, ensures effective regulating roles in the intestines, enhances biosafety and controllable release, and achieves effective regulation of intestinal health.
Smart Images

Figure CN115837007B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biotechnology, and specifically relates to an oral plant exosome hydrogel for targeted regulation of the intestine, and a preparation method and application thereof. Background Art
[0002] The intestine is the largest digestive organ in the human body. Studies have found that 80% of the digestion and absorption process is completed in the intestine. The intestine is not only the largest "nutrient supply center" of the human body, but also the largest immune system of the human body. Therefore, the integrity and functionality of the intestinal barrier are the fundamental guarantee for maintaining human health. Unhealthy and irregular living habits will accelerate intestinal aging, which can easily induce a variety of diseases. Regulating intestinal health is an important means to ensure human health.
[0003] Exosomes contain a variety of active substances, such as nucleic acids (mRNA, miRNA, IncRNA, circRNA), proteins, lipids and other substances. They are endogenous regulatory substances with multiple biological activities, which can affect the dynamic balance of the microbiome in the intestine and effectively regulate the intestine. Exosomes can be divided into animal cell exosomes and plant exosomes according to their sources. Animal cell exosomes have a wide range of sources and have good prospects for clinical application. However, exosomes from animal cells require the cultivation of a large number of cells, have a low yield, and have allogeneic immunogenicity problems. With the deepening of research, scientists have also discovered nanoparticles with physical properties and components similar to exosomes in the separation and purification of plants. Compared with animal exosomes, they have a higher yield and a shorter extraction cycle. They are derived from edible fruits and vegetables, have lower immunogenicity, and have broader application prospects. However, there are still the following problems when directly using plant exosome liquid or drying it: 1. The concentration of liquid exosomes is low, and the storage conditions are high, and it must be refrigerated for transportation; 2. Directly freeze-drying the exosomes, whether spray drying or freeze-vacuum drying, may damage the structure of the exosomes, and whether the exosome liquid or freeze-dried exosome powder is used directly, it is easily affected by bile salts, gastric acid, etc. after entering the body, and its biological activity and targeting performance will be greatly reduced. Chinese invention patent CN114009772A provides a method for preparing plant exosome microcapsule embedded freeze-dried powder, which forms plant exosome microcapsule embedded freeze-dried powder by primary coating of sodium alginate solution and secondary coating of chitosan oligosaccharide. However, the plant exosome freeze-dried powder obtained by this method still has problems such as low targeting efficiency and uncontrollable release, and the effect of directly applying it to intestinal regulation is not very ideal. Therefore, a method that can stably and targetedly regulate the intestine is needed. Summary of the invention
[0004] In order to overcome the shortcomings of the above-mentioned prior art, the purpose of the present invention is to provide an oral plant exosome hydrogel for targeted regulation of the intestine and a preparation method and application thereof, so as to stably and targetedly regulate the intestine.
[0005] In order to achieve the above object, the present invention adopts the following technical solutions:
[0006] The present invention discloses an oral plant exosome hydrogel for targeted regulation of the intestinal tract, comprising plant exosomes, porous starch and sodium alginate in a mass ratio of (0.01-0.5):(2.5-125):(10-500), wherein the plant exosomes are embedded in the internal pores of the porous starch, and the porous starch is embedded in the three-dimensional network structure of the sodium alginate.
[0007] Preferably, it also includes small peptide D3 and mixed phospholipids, and a mixture of plant exosomes, small peptide D3 and mixed phospholipids in a mass ratio of (0.01-0.5):(0.05-25)(1.5-125) is embedded in the internal pores of porous starch; the mixed phospholipids are a mixture of phospholipids and cholesterol.
[0008] Preferably, the particle size of the mixture of plant exosomes, small peptide D3 and mixed phospholipids ranges from 100 to 400 nm.
[0009] Preferably, the plant exosomes are extracted and separated under a pH value of 4 to 6.
[0010] Further preferably, the plant exosomes are extracted and separated after incubation with polyethylene glycol at a pH of 5.
[0011] Preferably, the plant exosomes are derived from tea leaves, mulberry bark, ginger, turmeric, onion, garlic or grapes.
[0012] The present invention also discloses a method for preparing the above-mentioned oral plant exosome hydrogel for targeted regulation of the intestine, which comprises taking the supernatant of plant juice, adjusting the pH value to 4-6, centrifuging and taking the precipitate to suspend in PBS buffer, taking the supernatant and filtering to obtain a plant exosome solution; mixing the plant exosome solution with a mixture of phospholipids and cholesterol to obtain plant exosome-liposomes; mixing the plant exosome-liposomes with porous starch, removing the supernatant to obtain plant exosome-liposome / porous starch particles; mixing the plant exosome-liposome / porous starch particles with sodium alginate, and then solidifying with a CaCl2 solution to obtain an oral plant exosome hydrogel.
[0013] Preferably, before centrifuging and collecting the precipitate, the supernatant of the plant juice adjusted to a pH value of 4 to 6 is mixed with polyethylene glycol and incubated.
[0014] Preferably, the obtained plant exosome-liposome / porous starch particles are mixed with starch gelatinized into a gel, and then mixed with sodium alginate.
[0015] The present invention also discloses the use of the above-mentioned oral plant exosome hydrogel for targeted intestinal regulation in the preparation of intestinal regulation drugs or health products.
[0016] Compared with the prior art, the present invention has the following beneficial effects:
[0017] The present invention provides an oral plant exosome hydrogel for targeted regulation of the intestine. The porous properties of porous starch are utilized. On the one hand, porous starch is used as an adsorption carrier of plant exosomes to protect plant exosomes and increase their stability. On the other hand, the properties of its natural polymer are utilized to form a composite gel with sodium alginate to further enhance the stability of the obtained gel. On the one hand, sodium alginate can shrink in gastric acid and swell in the near-neutral environment of the intestine, thereby avoiding the gastric environment and triggering release in the intestine. On the other hand, the combination of sodium alginate and porous starch utilizes the property of sodium alginate responding to changes in pH value. The amylase secreted by the feedback regulation of starchy food intake has a specific hydrolysis effect on porous starch, so that the obtained hydrogel has a trigger release platform for pH and amylase reaction. The preparation of this gel adopts a multi-stage embedding process. First, the gel shell formed by the sodium alginate in the outermost layer of the plant exosomes and the starch layer in the inner layer can protect it from passing through the stomach safely and smoothly after oral administration to stay in the small intestine and interact with the intestinal mucosa. At this time, the shell is gradually disintegrated under the dual stimulation response of intestinal pH and amylase, so that the exosomes inside can be slowly released. Secondly, this hierarchical structure can load more active substances to play a synergistic role, including small molecule compounds, macromolecular proteins, etc. Finally, the raw materials in the system have good biosafety and are edible, and can be used as a good carrier for oral delivery products. Therefore, the oral plant exosome hydrogel has good stability and can achieve multi-level targeted response delivery of plant exosomes, so as to better play the role of intestinal regulation.
[0018] Furthermore, the released exosomes are targeted to intestinal epithelial cells because of the small peptide D3 peptide on the membrane surface, which makes the exosome liposomes firmly anchored in the intestinal epithelial cells, and release the exosomes by fusing with the intestinal epithelial cell membrane to exert regulatory activity. The mixture of phospholipids and cholesterol can enhance the stability of plant exosomes on the one hand, and provide a more comprehensive delivery carrier with more active ingredients on the other hand.
[0019] Furthermore, the low-pH nanovesicle separation technology based on polyethylene glycol (PEG) can capture the nanovesicles in a network structure to maintain their integrity, which can greatly increase the yield of plant exosomes and increase the in vitro stability of exosomes without losing the integrity and key biological activities of plant exosomes. It is not only simple to operate, but also has a mild extraction process.
[0020] The present invention provides a method for preparing an oral plant exosome hydrogel for targeted regulation of the intestine, which adopts a multi-stage encapsulation process to sequentially encapsulate starch and sodium alginate in the outer layer of a mixture of plant exosomes and liposomes, thereby achieving stable targeted delivery of effective ingredients.
[0021] Furthermore, coating a layer of starch film on the surface of the porous starch granules can further enhance the stability and controlled release of the contents. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] Figure 1 This is a graph showing the total yield of PDNVs separated by different methods of the present invention;
[0023] Figure 2 It is a graph showing the total yield of PDNVs separated at different pH values of the present invention;
[0024] Figure 3 The transmission electron micrographs of PDNVs separated by different methods of the present invention are shown; A is PDNVs obtained by differential centrifugation, and B is PDNVs obtained by PEG precipitation under the condition of pH = 5;
[0025] Figure 4 The particle size and potential of PDNVs separated at different pH values of the present invention are shown in FIG.
[0026] Figure 5 The scanning electron microscope images of the porous starch and oral plant exosome hydrogel of the present invention; wherein A is porous starch, 20 μm; B is porous starch, 10 μm; C is oral plant exosome hydrogel, 20 μm; D is oral plant exosome hydrogel, 10 μm;
[0027] Figure 6 It is a statistical graph comparing the fluorescence intensity of gastrointestinal tissue of the oral plant exosome hydrogel of the present invention and exosomes, plant exosome-liposomes and plant exosome-liposomes / porous starch particles. DETAILED DESCRIPTION
[0028] In order to enable those skilled in the art to better understand the scheme of the present invention, the technical scheme in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work should fall within the scope of protection of the present invention.
[0029] It should be noted that the terms "including" and "having" and any variations thereof in the present invention are intended to cover non-exclusive inclusions. For example, a process, method, system, product or apparatus comprising a series of steps or units is not necessarily limited to those steps or units explicitly listed, but may include other steps or units not explicitly listed or inherent to these processes, methods, products or apparatuses.
[0030] The present invention is further described in detail below in conjunction with the accompanying drawings:
[0031] The present invention provides an oral plant exosome hydrogel for targeted regulation of the intestine, comprising plant exosomes, small peptide D3, mixed phospholipids, porous starch and sodium alginate in a mass ratio of (0.01-0.5):(0.05-25):(1.5-125):(2.5-125):(10-500); a mixture of plant exosomes, small peptide D3 and mixed phospholipids is fused to form a primary structure and embedded in the internal pores of the porous starch, and the porous starch is embedded in the three-dimensional network structure of the sodium alginate to form a secondary structure.
[0032] The source of the plant exosomes is any one of tea, mulberry bark, ginger, turmeric, onion, garlic, and grape; in the mixture of plant exosomes, small peptide D3 and mixed phospholipids, the final mass concentration of the plant exosomes is 0.02% to 0.1%, the final mass concentration of the small peptide D3 is 0.1% to 1%, and the final mass concentration of the liposomes is 3% to 5%; the mixed phospholipids are a mixture of phospholipids and cholesterol.
[0033] Example 1
[0034] 1. Extraction and separation of plant-derived nanovesicles (PDNVs)
[0035] The extraction and separation methods are as follows:
[0036] a) Weigh 10 g of fresh ginger after washing, crush it, add 100 g of sterile phosphate buffer, and homogenize it in a high-speed blender (750W, 3 min) to completely crush it;
[0037] b) then collecting the ginger juice by filtering with a 200 μm nylon mesh, and centrifuging the collected ginger juice for 30 min (2000 g, 10 min; 6000 g, 20 min);
[0038] c) then discarding the precipitate, adding 1 M HCl or NaOH to the supernatant to adjust the pH to pH = 5, mixing the pH-adjusted supernatant with PEG6000 and incubating at 4° C. overnight, wherein the final concentration of PEG6000 is 10% (w / v);
[0039] d) centrifugation (8000 g, 30 min), discarding the supernatant, and suspending the precipitate in PBS buffer at 0.5 mg / mL;
[0040] e) subsequently concentrating the solution obtained in d) through ultrafiltration through a 100 kd ultrafiltration tube, and discarding the liquid at the bottom of the ultrafiltration tube;
[0041] f) The concentrated liquid was filtered through a 0.22 μm filter membrane to obtain a ginger exosome solution; a transmission electron microscope (TecnaiG 2 20S-TWIN, FEI, USA) was used to observe the morphology of exosomes (specifically, a drop of the prepared sample was deposited on the surface of the copper grid, and then 1% uranyl acetate was added for staining for 15 seconds, and then the sample was allowed to dry at room temperature for subsequent TEM imaging). The particle size and surface charge of the exosomes were measured using a nanoparticle size analyzer (Malvern Instruments, Malvern, UK) (specifically, the exosome sample was diluted 100 times, added to the sample pool for measurement, and each sample was repeated three times). The protein concentration of the ginger exosome solution was determined using the standard operating method of the BCA kit, and its concentration was adjusted to 5.0 mg / mL, and stored at -80°C as a storage solution to avoid repeated freezing and thawing.
[0042] At the same time, in order to determine the beneficial effect of low pH on exosome extraction, we further used different pH values to extract exosomes, that is, the pH value in step c) was adjusted to pH = 6 and pH = 7, respectively, and the other steps were the same.
[0043] In order to further compare the differences in exosomes prepared by different extraction methods, ginger exosomes were prepared by differential centrifugation. The specific method was as follows: 1 g of fresh ginger was initially crushed, 100 g of sterile phosphate buffer was added, and it was homogenized in a high-speed blender (750 W, 3 min) to completely break it; then the ginger juice was filtered through a 200 μm nylon mesh to collect the ginger juice, and the collected ginger juice was centrifuged at 1000 g for the first time for 10 min, the supernatant from the first centrifugation was taken and continued to be centrifuged at 3000 g for a second time for 20 min, and the supernatant from the second centrifugation was taken and centrifuged at 10000 g for a third time for 40 min to remove impurities, and finally the supernatant from the third centrifugation was collected and centrifuged at 100000 g for a fourth time for 90 min, and the precipitate was washed three times with PBS to obtain the ginger exosomes.
[0044] The exosome yield was calculated by the following formula: exosome yield = mass of collected ginger exosomes / mass of input fresh ginger.
[0045] The results are as follows Figure 1 and Figure 2 , Figure 1 This indicates that compared with differential centrifugation, the low pH precipitation method can produce a higher yield of exosomes. Figure 2 It further showed that lowering the pH value to a weakly acidic environment was more conducive to increasing the exosome yield. Figure 3 The results further showed that both the low pH precipitation method and differential centrifugation method could produce exosomes with vesicle-like structures, but the exosomes prepared by the low pH precipitation method were smaller in size. Figure 4 The particle size and surface charge of exosomes prepared under different pH conditions further showed that there was no obvious difference in their surface charge, but the size of exosomes increased significantly with the increase of extraction pH, and the exosomes isolated under low pH conditions had a smaller particle size.
[0046] 2. Preparation of plant-derived nanovesicles-liposomes (PDNVs-LP)
[0047] Weigh the small peptide D3 (reference the synthesis sequence and method in the literature "A novel peptide protects against diet-induced obesity by suppressing appetite and modulating the gut microbiota") and add it to the Pro-Lipo TMNeo (purchased from Sage Chemical (Group) Co., Ltd), mixed evenly to obtain a phospholipid mixture; weigh the ginger exosome solution obtained in step 1, and slowly inject it into the phospholipid mixture under stirring, with an injection speed of 1-4% V / min, and a stirring speed of 800-1000 rpm / min for the phospholipid mixture. After completion, continue stirring for 10 minutes, and then perform gradient homogenization to prepare plant exosomes-liposomes (PDNVs-LP) with a particle size range of 100-400 nm.
[0048] Among them, the final mass concentration of peptide D3 was 0.5%, the final mass concentration of ginger exosomes was 0.05%, and Pro-Lipo TM The final mass concentration of Neo was 5%.
[0049] 3. Hydrogel Preparation
[0050] (1) Preparation of porous starch (PS)
[0051] Weigh 5g corn starch (Maize starch, MS, purchased from Ingredients Co., Ltd.) and add it to 95g PBS buffer to form starch slurry, then add 12.5g Bacillus subtilis derived α-amylase (4000U / g, purchased from Sigma-Aldrich) and mix with the starch slurry, stir in a water bath at 37°C overnight, and the speed is 200rpm / min. After the reaction is completed, collect the suspension and centrifuge at 3000g for 10min, then add 2 times the mass of anhydrous ethanol to wash the precipitate 3 times. Finally, place the precipitate in an oven to dry (40°C, overnight) to obtain porous starch.
[0052] Porous starch can also be purchased directly, and the purchase selection source is porous starch from corn, potato, rice, wheat, barley or cassava.
[0053] (2) Plant exosomes-liposomes / porous starch particles (PDNVs-LP / PS)
[0054] Weigh 200 g of the PDNVs-LP obtained in step 2 and 10 g of the PS obtained in step 3 (1), stir at room temperature to mix them evenly (500 rpm, 60 min), then let stand for 2 h, then gently remove the supernatant, pre-freeze at -20°C for 4 h, and then freeze-dry overnight to obtain PDNVs-LP / PS.
[0055] Furthermore, in order to prevent the PDNVs-LP embedded in the internal pores of PS from leaking in the subsequent operation steps, resulting in a reduction in effective ingredients, a starch gel film was coated on the outer layer of PDNVs-LP / PS. The specific steps are as follows:
[0056] Weigh 2 g of G70 high-amylose corn starch (purchased from Ingredion Food Ingredients Co., Ltd.) and dissolve it in 98 g of deionized water. Heat it until it becomes gelatinized and cool it to room temperature. Then weigh 100 g of gel and 50 g of PDNVs-LP / PS and mix them carefully. Pre-freeze it at -20°C overnight and freeze-dry it for 24 hours to obtain plant exosomes-liposomes / porous starch particles coated with corn starch.
[0057] (3) Plant exosomes-liposomes / porous starch / gel (PDNVs-LP / PS / SA)
[0058] Weigh 4.8g of the above-mentioned corn starch-coated plant exosome-liposome / porous starch particles, add 15.2g of deionized water and stir to completely dissolve it. Then weigh 0.8g of sodium alginate (SA, purchased from Shanghai Aladdin Biochemical Technology Co., Ltd.) and add it to 19.2g of deionized water to completely dissolve it, then mix the two at room temperature and stir to mix them evenly (500rpm / min, 30min), use a peristaltic pump to drip the above mixture through a needle tip (inner diameter 0.51mm) into 100mL of CaCl2 solution (1.5% w / v) to solidify and form hydrogel microbeads, and rinse the microbeads with a large amount of ultrapure water 2 to 3 times to obtain an oral plant exosome hydrogel that targets and regulates the intestine.
[0059] 4. System evaluation experiment
[0060] (1) Electron microscopy characterization
[0061] The surface structure of porous starch and composite hydrogel after freeze-drying was observed using a scanning electron microscope (SEM, Hitachi, Regulus8100, Japan). A small amount of sample was placed on the conductive glue, sprayed with gold for 2 minutes under vacuum, and then the SEM image was obtained at a working voltage of 10 kV. Figure 5 As can be seen in Figures A and B, the prepared starch granules present a porous structure with multiple nearly circular micropores. This multi-porous structure is conducive to embedding more contents. Figure 5 As can be seen in C and D, the oral plant exosome hydrogel is approximately spherical after freeze-drying, with faintly visible small holes inside, but after magnification, it can be seen that the surface is covered with a membrane.
[0062] (2) In vitro gastric acid resistance test
[0063] The concentration of free plant exosomes was determined by incubating the above-mentioned plant exosomes, plant exosome-liposomes, plant exosome-liposomes / porous starch particles, and oral plant exosome hydrogels with simulated gastric fluid. The specific method is as follows:
[0064] ① Preparation of simulated gastric fluid: Use concentrated hydrochloric acid to adjust the pH of 2 mg / mL NaCl solution to pH = 2.0, then add a certain amount of pepsin, the final concentration of pepsin is 0.3 mg / mL, and then filter with a 0.22 μm filter membrane for sterilization and use.
[0065] ② Take 1g of plant exosomes, plant exosome-liposomes, plant exosome-liposomes / porous starch particles and oral plant exosome hydrogel, place them in 9mL simulated gastric fluid preheated at 37℃, and then place them in a constant temperature shaker for incubation (37℃, 100rpm / min). At intervals of 10min, 30min, 60min, 120min and 180min, take 1mL of each of the above four mixed solutions, add them to sterile phosphate buffer containing 0.2mol / L NaHCO3, shake for 30min, and then use the BCA method to determine the concentration of free plant exosomes. The results are shown in Table 1:
[0066] Table 1 Results of gastric acid resistance experiment of plant exosomes in each group
[0067]
[0068]
[0069] The results in Table 1 indicate that hierarchical encapsulation of plant exosomes can enhance the gastric acid resistance stability of plant exosomes.
[0070] (3) Stability in an in vitro simulated digestive tract system
[0071] The concentration of free plant exosomes was determined by incubating the simulated digestive tract fluid with the above-mentioned plant exosomes, plant exosome-liposomes, plant exosome-liposomes / porous starch particles, and oral plant exosome hydrogel. The specific method is as follows:
[0072] ① Establish simulation models of each digestive tract simulation fluid, see Table 2:
[0073] Table 2 pH values and action schedules of various digestive tract simulation fluids
[0074]
[0075] Among them, the digestive tract simulation fluid of stage 1 to stage 6 is a simulation fluid that simulates the continuous process from esophagus to stomach, and the preparation method is as follows: 5 mg / mL of pepsin is dissolved in normal saline, and the pH value is adjusted to the specified value and then filtered and sterilized.
[0076] The digestive tract simulation fluid of stage 7 is the duodenal simulation fluid, and the preparation method is as follows: 10 mg / mL of trypsin and 3 mg / mL of bile salt are dissolved in normal saline, the pH value is adjusted to 5.0, and then filtered for sterilization.
[0077] The digestive tract simulation fluid in stage 8 is the small intestine simulation fluid, and the preparation method is as follows: 10 mg / mL of trypsin and 3 mg / mL of bile salt are dissolved in normal saline, 0.1 mol / L of NaHCO3 is added, and then the pH value is adjusted to 6.5 and filtered for sterilization.
[0078] ② Take 1g of plant exosomes, plant exosome-liposomes, plant exosome-liposomes / porous starch particles and oral plant exosome hydrogels, place them in 9mL simulated digestion solution preheated at 37℃, and then place them in a constant temperature shaker for incubation (37℃, 100rpm / min). After the action time is over, replace the next stage of simulation solution. Before each replacement of the simulation solution, centrifuge at 10000rpm / min for 2min, discard the supernatant and add the new stage simulation solution, vortex for 30s to mix thoroughly. Take 1mL of each of the above four groups of mixed solutions after action, add them to sterile phosphate buffer containing 0.2mol / L NaHCO3, shake for 30min, and then determine the concentration of free plant exosomes by BCA method. The results are shown in Table 3:
[0079] Table 3 Stability of plant exosomes in each group in the simulated digestive tract
[0080]
[0081] The results in Table 3 show that plant exosomes will be damaged to a certain extent in the digestive system. This may be due to the fact that the pH value of the system has a certain destructive effect on its structure. This damage loss can be reduced through different encapsulation methods, especially the oral plant exosome hydrogel system, which can better protect the exosomes from being destroyed by the digestive system.
[0082] 5. Evaluation of the effect of targeted regulation of the intestine
[0083] (1) Intestinal targeting
[0084] ① Experimental animal selection
[0085] Female C57BL / 6 mice (6-8 weeks old) and Sprague-Dawley rats (4-6 weeks old) were purchased from Beijing Weitong Lihua Laboratory Animal Technology Co., Ltd. and were fed adaptively for one week in a pathogen-free clean animal room according to standard procedures before the experiment. All experiments involving mice were approved by the Animal Ethics Committee of the Experimental Animal Center of the Air Force Medical University.
[0086] ②Preparation of fluorescently labeled plant exosome hydrogel
[0087] PDNVs were labeled with the fluorescent lipophilic dye DiR (purchased from Sigma). The specific method is as follows: 0.5 mg of PDNVs was weighed and added to 1 mL of PBS buffer, 1 μL of DiR dye was added thereto, and incubated at room temperature in the dark for 30 minutes. The labeled PDNVs were then passed through a 100 kD ultrafiltration centrifuge tube to remove the free dye to obtain fluorescently labeled plant exosomes (DiR-PDNVs). The fluorescently labeled exosomes were then used to prepare exosome hydrogels in the same manner.
[0088] ③ Fluorescence distribution in vivo
[0089] In order to confirm its intestinal targeting, the prepared plant exosome hydrogel was evenly mixed with feed, and mice fasted for 12 hours were orally ingested by gavage, with each mouse taking 5g. The mice were killed 12 hours after oral administration, and stomach and intestinal tissues were collected. Fluorescence imaging was performed using the IVIS Spectrum Series In Vivo Imaging System, and the fluorescence intensity of each tissue was counted.
[0090] The results are as follows Figure 6 After hierarchical encapsulation, the fluorescence intensity of the oral plant exosome gel in gastric tissue was higher, indicating that it has good intestinal targeting and can act on the intestine for a longer time.
[0091] (2) Intestinal regulation effect
[0092] The rats were randomly divided into two groups. The control group was fed 30g of normal feed every day, and the experimental group was fed 15g of plant exosome hydrogel and 15g of normal feed every day. The feeding was the same for 14 days. The condition of the rats was observed and recorded every day, and they were weighed twice a week at the same time. It was found that the SD rats were agile, had smooth fur, ate and drank normally, and gained weight normally during the experiment. There was no obvious abnormal pathology or death.
[0093] At the same time, rat feces were collected 4 days before the end of the experiment and immediately frozen in a -80°C refrigerator after collection every day. Then 2g of rat feces was weighed and placed in a 200mL sterile ground-mouth flask containing 0.1% peptone diluent. The feces sample was mixed with vigorous shaking. After mixing, the feces sample was gradiently diluted to a sterilized anaerobic tube containing 9mL 0.1% peptone diluent. Then, 200 μL of the feces sample after appropriate dilution was added to the five solid plate culture media (BBL agar, bile seven night glycoside sodium azide agar, crystal violet neutral red bile salt agar, MRS lactic acid bacteria agar), and spread evenly. It was used to culture bifidobacteria, enterococci, Escherichia coli, lactobacilli, etc., respectively, where MRS lactic acid bacteria agar was placed in an anaerobic tank at 37°C for 48h, and the other three were directly placed in a 37°C aerobic incubator for 24h. Then, the colonies on each plate were counted according to the standard plate counting method, and the results are shown in Table 4 below:
[0094] Table 4 Statistical table of plate counts of four types of fecal bacteria
[0095]
[0096] Note: The results are in log 10 indicates, * indicates significant difference compared with the normal feed group P<0.05.
[0097] Through the above results, after feeding the plant exosome hydrogel, the content of beneficial bacteria Bifidobacterium and Lactobacillus increased, and the number of pathogenic bacteria Enterococcus and Escherichia coli decreased, indicating that it can play a beneficial role in regulating the intestine by affecting the intestinal flora and improving the distribution of intestinal flora.
[0098] At the same time, 2g of rat feces collected for 4 consecutive days were taken, placed in an oven at 105°C and dried to constant weight, and the weight after drying was measured to calculate the water content: feces water content (weight %) = (feces wet weight - feces dry weight) / feces wet weight × 100% = water weight / feces wet weight × 100%. The results are shown in Table 5:
[0099] Table 5 Fecal moisture statistics
[0100]
[0101]
[0102] Note: * indicates significant difference compared with the normal diet group (P<0.05).
[0103] The results in Table 5 show that the feces of rats fed with plant exosome hydrogel had a higher water content. Metabolite feces is one of the important indicators of body health and intestinal health. The increase in the content of beneficial bacteria in the intestinal flora will soften the feces, increase the water content of the feces, and promote fecal excretion.
[0104] At the same time, 0.4 g of rat feces was taken, added to 4 mL of sterile double distilled water, shaken and mixed thoroughly, and placed at room temperature overnight. The next day, it was shaken vigorously again to completely disperse into a homogenate, centrifuged at 4000 rpm / min for 10 min at 4°C, and then 250 μL of the supernatant was taken and placed in a 1.5 mL centrifuge tube and stored in a 4°C refrigerator. 50 μL of it was taken to measure the pH value, and 20 μL of 32 mmol / L α-methylvaleric acid and 20 μL of phosphoric acid (1:5) were added to the remaining 200 μL of supernatant. After centrifugation at 12000 rpm / min for 15 min, the supernatant was taken, filtered through a 0.22 μm filter membrane, and injected into a gas chromatograph to automatically obtain the peak areas of acetic acid, propionic acid, and butyric acid. The content of the above three short-chain fatty acids (SCFA) in the sample was calculated based on the peak areas. Chromatographic conditions are as follows: the chromatographic column is RtxWAX667536, with dimensions of 32m×0.32mm×0.25mm, the temperature of the chromatographic injector and detector are both 250°C, the column temperature is 80°C, the nitrogen flow rate is 1.94mL / min, the injection is performed in split mode, and the injection volume is 2μL. At the same time, 150mmol / L acetic acid, 50mmol / L butyric acid, and 40mmol / L normal butyric acid are accurately prepared with analytical reagents as standard solutions, and 32mmol / L α-methylvaleric acid is used as the internal standard solution. The results are shown in Table 6:
[0105] Table 6 Statistics of changes in fecal pH and short-chain fatty acids
[0106] Feeding pH Acetic acid (μmol / g) Propionic acid (μmol / g) Butyric acid (μmol / g) Normal feed 7.02±0.06 32.28±1.51 8.86±0.81 8.15±0.62 Feed + Plant Exosome Hydrogel 6.84±0.08 35.52±1.27* 10.62±0.54* 8.17±1.12
[0107] Note: * indicates significant difference compared with the normal diet group (P<0.05).
[0108] From the above results, the fecal pH value of rats in the plant exosome hydrogel feeding group decreased, and the content of short-chain fatty acids also changed, among which butyric acid increased slightly, while the content of acetic acid and propionic acid increased significantly. The dominant beneficial bacteria in the intestinal flora, such as bifidobacteria and lactobacilli, are anaerobic bacteria. In the presence of suitable substrates, anaerobic bacteria can ferment substrates to produce short-chain fatty acids, among which acetic acid, propionic acid, and butyric acid have the highest content and are the main SCFA in the intestine. SCFA can increase the excretion of bile acid through feces, reduce the cytotoxic effect of feces, reduce the proliferation of rectal cells, and promote intestinal health.
[0109] Example 2
[0110] An oral plant exosome hydrogel for targeted intestinal regulation, comprising tea exosomes, small peptide D3, Pro-Lipo TM Neo, porous starch and sodium alginate; tea exosomes, small peptide D3 and Pro-Lipo TMNeo mixture fused to form a primary structure and embedded in the internal pores of porous starch, in which the final concentration of tea exosomes in the primary structure was 0.02%, the final concentration of small peptide D3 was 0.1%, and Pro-Lipo TM The final concentration of Neo is 3%; the porous starch is embedded in the three-dimensional network structure of sodium alginate to form a secondary structure.
[0111] The preparation method of the above-mentioned oral plant exosome hydrogel is the same as that in Example 1.
[0112] Example 3
[0113] An oral plant exosome hydrogel for targeted intestinal regulation, comprising turmeric exosomes, small peptide D3, Pro-Lipo TM Neo, porous starch and sodium alginate; turmeric exosomes, small peptide D3 and Pro-Lipo TM Neo mixture fused to form a primary structure and embedded in the internal pores of porous starch, in which the final concentration of turmeric exosomes in the primary structure was 0.05%, the final concentration of small peptide D3 was 0.5%, and Pro-Lipo TM The final concentration of Neo is 3%; the porous starch is embedded in the three-dimensional network structure of sodium alginate to form a secondary structure.
[0114] The preparation method of the above-mentioned oral plant exosome hydrogel is the same as that in Example 1.
[0115] Example 4
[0116] An oral plant exosome hydrogel for targeted intestinal regulation, comprising grape exosomes, small peptide D3, Pro-Lipo TM Neo, porous starch and sodium alginate; grape exosomes, small peptide D3 and Pro-Lipo TM Neo mixture fused to form a primary structure and embedded in the internal pores of porous starch, in which the final concentration of grape exosomes in the primary structure was 0.06%, the final concentration of small peptide D3 was 1%, and Pro-Lipo TM The final concentration of Neo is 4%; the porous starch is embedded in the three-dimensional network structure of sodium alginate to form a secondary structure.
[0117] The preparation method of the above-mentioned oral plant exosome hydrogel is the same as that in Example 1.
[0118] Example 5
[0119] An oral plant exosome hydrogel for targeted intestinal regulation, comprising mulberry bark exosomes, small peptide D3, Pro-Lipo TMNeo, porous starch and sodium alginate; mulberry bark exosomes, small peptide D3 and Pro-Lipo TM Neo mixture fused to form a primary structure and embedded in the internal pores of porous starch, in which the final concentration of mulberry bark exosomes in the primary structure was 0.04%, the final concentration of small peptide D3 was 0.2%, and Pro-Lipo TM The final concentration of Neo is 3%; the porous starch is embedded in the three-dimensional network structure of sodium alginate to form a secondary structure.
[0120] The preparation method of the oral plant exosome hydrogel is the same as that in Example 1.
[0121] Example 6
[0122] An oral plant exosome hydrogel for targeted intestinal regulation, comprising onion exosomes, small peptide D3, Pro-Lipo TM Neo, porous starch and sodium alginate; onion exosomes, small peptide D3 and Pro-Lipo TM Neo mixture fused to form a primary structure and embedded in the internal pores of porous starch, in which the final concentration of onion exosomes in the primary structure was 0.05%, the final concentration of small peptide D3 was 1%, and Pro-Lipo TM The final concentration of Neo is 4%; the porous starch is embedded in the three-dimensional network structure of sodium alginate to form a secondary structure.
[0123] The preparation method of the above-mentioned oral plant exosome hydrogel is the same as that in Example 1.
[0124] Example 7
[0125] An oral plant exosome hydrogel for targeted intestinal regulation, comprising garlic exosomes, small peptide D3, Pro-Lipo TM Neo, porous starch and sodium alginate; garlic exosomes, small peptide D3 and Pro-Lipo TM Neo mixture fused to form a primary structure and embedded in the internal pores of porous starch, in which the final concentration of garlic exosomes in the primary structure was 0.1%, the final concentration of small peptide D3 was 1%, and Pro-Lipo TM The final concentration of Neo is 5%; the porous starch is embedded in the three-dimensional network structure of sodium alginate to form a secondary structure.
[0126] The preparation method of the above-mentioned oral plant exosome hydrogel is the same as that in Example 1.
[0127] The above contents are only for explaining the technical idea of the present invention and cannot be used to limit the protection scope of the present invention. Any changes made on the basis of the technical solution in accordance with the technical idea proposed by the present invention shall fall within the protection scope of the claims of the present invention.
Claims
1. An oral plant exosome hydrogel for targeted regulation of the intestine, characterized in that: It includes plant exosomes, porous starch and sodium alginate in a mass ratio of (0.01-0.5): (2.5-125): (10-500), and also includes small peptide D3 and mixed phospholipids; the plant exosomes are derived from ginger, and the mixed phospholipids are a mixture of phospholipids and cholesterol; The plant exosomes are embedded in the internal pores of porous starch, the porous starch is embedded in the three-dimensional network structure of sodium alginate, and a mixture of plant exosomes, small peptide D3 and mixed phospholipids in a mass ratio of (0.01-0.5): (0.05-25): (1.5-125) is embedded in the internal pores of porous starch.
2. The oral plant exosome hydrogel for targeted regulation of the intestinal tract according to claim 1, characterized in that: The particle size of the mixture of plant exosomes, small peptide D3 and mixed phospholipids ranges from 100 to 400 nm.
3. The oral plant exosome hydrogel for targeted regulation of the intestinal tract according to claim 1 or 2, characterized in that: The plant exosomes are extracted and separated under the condition of pH value of 4-6.
4. The oral plant exosome hydrogel for targeted regulation of the intestinal tract according to claim 3, characterized in that: The plant exosomes are extracted and separated after being incubated with polyethylene glycol under a pH value of 5.
5. The method for preparing an oral plant exosome hydrogel for targeted regulation of the intestinal tract according to any one of claims 1 to 4, characterized in that: The supernatant of the plant juice was taken, the pH value was adjusted to 4-6, the precipitate was centrifuged and suspended in PBS buffer, the supernatant was taken and filtered to obtain a plant exosome solution; the plant exosome solution was mixed with a mixture of small peptide D3, phospholipids and cholesterol to obtain plant exosome-liposomes; the plant exosome-liposomes were mixed with porous starch, the supernatant was removed, and plant exosome-liposome / porous starch particles were obtained; the plant exosome-liposome / porous starch particles were mixed with sodium alginate, and then solidified with CaCl2 solution to obtain an oral plant exosome hydrogel.
6. The method for preparing an oral plant exosome hydrogel for targeted regulation of the intestinal tract according to claim 5, characterized in that: Before centrifugation to obtain the precipitate, the supernatant of the plant juice adjusted to a pH value of 4-6 was mixed with polyethylene glycol and incubated.
7. The oral plant exosome hydrogel for targeted regulation of the intestinal tract according to claim 6, characterized in that: The obtained plant exosome-liposome / porous starch particles are mixed with starch gelatinized into a gel, and then mixed with sodium alginate.
8. Use of an oral plant exosome hydrogel for targeted intestinal regulation according to any one of claims 1 to 4 in the preparation of intestinal regulating drugs or health products.
